Verified Nov 2026
Batteries & E-Mobility
·

Cambridge, Massachusetts
·
Since 1993
Takeda Oncology is the oncology specialty division of Takeda Pharmaceutical Company Limited, headquartered in Cambridge, Massachusetts. Established as Millennium Pharmaceuticals in 1993 and acquired by Takeda in 2008, the division employs 1,000 to 5,000 people and generates an estimated $1–5 billion in revenue. It develops and manufactures oncology therapies targeting thoracic, gastrointestinal, and hematologic cancers using antibody-drug conjugates, complex biologics, and small molecules, serving the medical and pharmaceutical industries across 10 countries with manufacturing in seven locations.
Takeda Oncology at a glance
Revenue
$1-5B
Est. band
Employees
1,000-5,000
Founded
1993
Headquarters
Cambridge, Massachusetts
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Takeda Oncology is the oncology specialty division of Takeda Pharmaceutical Company Limited, headquartered in Cambridge, Massachusetts. Established as Millennium Pharmaceuticals in 1993 and acquired by Takeda in 2008, the division employs 1,000 to 5,000 people and generates an estimated $1–5 billion in revenue. It develops and manufactures oncology therapies targeting thoracic, gastrointestinal, and hematologic cancers using antibody-drug conjugates, complex biologics, and small molecules, serving the medical and pharmaceutical industries across 10 countries with manufacturing in seven locations.
At a glance
Attribute | Detail |
|---|---|
Founded | 1993 |
Headquarters | Cambridge, Massachusetts |
Employees | 1,000-5,000 |
Revenue | $1-5B (estimated) |
Primary capability | Batteries & E-Mobility |
What Takeda Oncology makes
The company specializes in drug discovery, clinical research, and manufacturing of targeted biologics including antibody-drug conjugates and small-molecule therapeutics for cancer treatment.
Products and capabilities described on the company's own site include LED (source: takedaoncology.com).
Latest developments
2026-11-12 — Takeda Highlights Oncology and Hematology Research at ASH 2026 (takedaoncology.com)
2026-11-12 — Oncology News & Updates | Takeda Cancer Research (takedaoncology.com)
2026-09-16 — Takeda Receives Approval for ELAHERE® (mirvetuximab soravtansine) in Japan for the Treatment of Folate Receptor Alpha-Positive, Platinum-Resistant Recurrent Ovarian Cancer (takeda.com)
2025-12-30 — XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab :: XOMA Royalty Corporation (XOMA) (xoma.com)
2025-12-04 — Takeda’s Strategic Partnership with Innovent Closes (takedaoncology.com)
2025-10-21 — Takeda Announces Oncology Partnership with Innovent (takedaoncology.com)
Facilities
Takeda Oncology is headquartered in Cambridge, Massachusetts. Public sources also reference these locations:
Boston, Massachusetts — takedaoncology.com
Linz, Austria — takeda.com
Tampa, FL — lonza.com
Company details
Takeda Oncology operates manufacturing centers in seven countries and maintains facilities in Boston, Linz, and Tampa, supporting its global oncology pipeline and patient access initiatives. Takeda Oncology was founded in 1993, has an estimated 1,000-5,000 employees, and is headquartered in Cambridge, Massachusetts.
Frequently asked questions
What does Takeda Oncology make?
Takeda Oncology is the oncology specialty division of Takeda Pharmaceutical Company Limited, headquartered in Cambridge, Massachusetts. Established as Millennium Pharmaceuticals in 1993 and acquired by Takeda in 2008, the division employs 1,000 to 5,000 people and generates an estimated $1–5 billion in revenue. It develops and manufactures oncology therapies targeting thoracic, gastrointestinal, and hematologic cancers using antibody-drug conjugates, complex biologics, and small molecules, serving the medical and pharmaceutical industries across 10 countries with manufacturing in seven locations.
Where is Takeda Oncology headquartered?
Takeda Oncology is headquartered in Cambridge, Massachusetts (40 Landsdowne Street, Cambridge, Massachusetts, 02139).
When was Takeda Oncology founded?
Takeda Oncology was founded in 1993.
How big is Takeda Oncology?
Takeda Oncology has an estimated 1,000-5,000 employees, with revenue in the $1-5B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
